par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • July 16th, 2015 • Cancer Genetics, Inc • Services-medical laboratories • New York
Contract Type FiledJuly 16th, 2015 Company Industry JurisdictionCancer Genetics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: